Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney... Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney, Australia, the company has over 40 years of experience and holds approximately 60% of the global cochlear implant market share. Cochlear Limited serves both developed and emerging markets, with a strong focus on children and adults experiencing severe to profound hearing loss. Its products are distributed across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Listed on the CHI-X Market Australia – Limit Venue, Cochlear Limited operates within the healthcare sector and is recognized for its innovation, robust financial performance, and significant contribution to improving hearing outcomes worldwide. The company’s shares are actively traded, reflecting its prominence in the medical technology industry.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Cochlear is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Cochlear is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Cochlear's data?

Start your 30-day free trial to request a data review for Cochlear.

Start Free Trial

Legal Center Contact Us